ストックスクリーナーアプリを入手
3.24
0.77%
-0.025
アフターアワーズ：
3.34
0.10
+3.09%
Anixa Biosciences Inc (ANIX) 最新ニュース
How strong is Anixa Biosciences Inc. stock balance sheetJuly 2025 Market Mood & Safe Capital Growth Tips - Улправда
Aug Action: Why Anixa Biosciences Inc stock could be next big winnerMarket Movers & Fast Momentum Entry Tips - moha.gov.vn
Anixa Biosciences takes over breast cancer vaccine IND from Cleveland Clinic - Investing.com Australia
Anixa Biosciences, Inc. (ANIX) Stock Price, News, Quote & History - Yahoo Finance
ANIX: Breast cancer vaccine phase I showed 75% robust immune response and strong safety profile - TradingView — Track All Markets
Anixa Biosciences falls on phase 1 data for breast cancer vaccine - MSN
Cleveland Clinic transfers breast cancer vaccine IND to Anixa - marketscreener.com
Anixa Biosciences (ANIX) Advances Breast Cancer Vaccine Developm - GuruFocus
Anixa Biosciences takes over breast cancer vaccine IND from Cleveland Clinic By Investing.com - Investing.com South Africa
Anixa Biosciences (NASDAQ: ANIX) assumes IND, plans Phase 2 cancer vaccine trial - Stock Titan
D. Boral Capital Maintains Anixa Biosciences (ANIX) Buy Recommendation - Nasdaq
Anixa Biosciences (ANIX) Shares Drop 21% After Phase 1 Vaccine D - GuruFocus
Anixa Biosciences (NASDAQ:ANIX) Given "Buy" Rating at D. Boral Capital - MarketBeat
ANIX: D. Boral Capital Maintains Buy Rating with $10 Price Targe - GuruFocus
Anixa Biosciences Reports Positive Phase 1 Trial Results - TipRanks
Anixa Biosciences Inc Announces Positive Phase 1 Data for Breast Cancer Vaccine - TradingView — Track All Markets
Anixa Biosciences Says Breast Cancer Vaccine Candidate Meets Key Endpoints in Phase 1 Trial - marketscreener.com
Anixa Biosciences Shares Jump Over 15% In After-Hours Trading — Here's Why - Benzinga
D Boral Capital maintains Anixa Biosciences (ANIX) buy recommendation - MSN
Anixa Biosciences (ANIX) Presents Promising Phase 1 Breast Cance - GuruFocus
Anixa Biosciences (NASDAQ: ANIX) presents final Phase 1 breast cancer vaccine data - Stock Titan
Anixa’s breast cancer vaccine shows positive Phase 1 results - Investing.com
Anixa Biosciences Announces Positive Phase 1 Data for Investigational Breast Cancer Vaccine; Primary Endpoints Were Met and Immune Response Observed in 74% of Participants - WV News
Cleveland Clinic Presents Final Results of Phase 1 Clinical Trial of Preventive Breast Cancer Vaccine Study - Cleveland Clinic Newsroom
Anixa Biosciences to Participate in Water Tower Research Fireside Chat on Monday, December 15, 2025 - WV News
Anixa Biosciences Inc (NASDAQ:ANIX) Given Average Rating of "Hold" by Brokerages - MarketBeat
Anixa Biosciences (NASDAQ: ANIX) sets Dec. 15 talk on Phase 1 breast cancer vaccine - Stock Titan
Anixa Biosciences (NASDAQ: ANIX) unveils final Phase 1 breast cancer vaccine results at 2025 SABCS - Stock Titan
Will Anixa Biosciences Inc. (CY71) stock beat Nasdaq index returns2025 Risk Factors & Real-Time Stock Entry Alerts - Newser
Why Anixa Biosciences Inc. (CY71) stock is trending on social mediaPortfolio Update Report & Fast Momentum Stock Entry Tips - Newser
Will Anixa Biosciences Inc. stock see PE expansionWeekly Trading Summary & Risk Controlled Stock Pick Alerts - Newser
Is Anixa Biosciences Inc. stock undervalued vs historical averagesJuly 2025 WrapUp & Free Technical Pattern Based Buy Signals - Newser
Who are in the management team of Anixa Biosciences, Inc.? - Markets Mojo
Is Anixa Biosciences Inc. stock a bargain at current levelsJuly 2025 Opening Moves & Community Consensus Stock Picks - Newser
How risky is Anixa Biosciences Inc. (CY71) stock compared to peersLayoff News & Accurate Intraday Trading Signals - Newser
Can Anixa Biosciences Inc. (CY71) stock sustain double digit ROEJuly 2025 Action & Stepwise Trade Signal Implementation - Newser
How Anixa Biosciences Inc. stock compares to growth peersJuly 2025 Catalysts & Risk Adjusted Buy/Sell Alerts - Newser
Anixa Biosciences (ANIX) Stock Analysis Report | Financials & Insights - Benzinga
Why retail investors pile into Anixa Biosciences Inc. stock2025 Institutional Moves & High Accuracy Trade Alerts - moha.gov.vn
Anixa Biosciences Announces Completion of Final Patient Visit in Breast Cancer Vaccine Clinical Trial (PR Newswire) - Aktiellt
Can Anixa Biosciences Inc. stock attract ESG capital inflows2025 Top Decliners & Low Risk High Win Rate Stock Picks - moha.gov.vn
Anixa Biosciences Announces World Health Organization (WHO) Approval of International Non-Proprietary Name for its CAR-T Therapy, Marking a Key Milestone Toward Global Recognition and Future Commercialization - Quantisnow
Anixa Biosciences (NASDAQ:ANIX) Stock Rating Lowered by Zacks Research - MarketBeat
Is Anixa Biosciences Inc. stock a top momentum playGold Moves & Precise Entry and Exit Recommendations - newser.com
How geopolitical risks impact Anixa Biosciences Inc. (CY71) stockWeekly Trade Recap & High Return Trade Guides - newser.com
Why Anixa Biosciences Inc. stock is recommended by analysts2025 Risk Factors & Long-Term Growth Portfolio Plans - newser.com
Anixa Biosciences (ANIX) Price Target Increased by 11.11% to 10.20 - MSN
0.31%
0.33%
大文字化:
|
ボリューム (24 時間):